Datasets:
Suchinthana
/
support2-1

Dataset card Data Studio Files
xet
Community
1
ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
9,001
82.21497
1
male
1
26
26
COPD
COPD/CHF/Cirrhosis
3
null
null
0
54,639
38,227.9688
41,906.5
33
white
42
57
0.20697
0.063995
1
0
0
no
0.55
0.55
dnr after sadm
18
73
16.199219
120
14
38.19531
198.15625
1.399902
1.799805
0.899902
132
7.40918
183
36
1,610
null
null
<2 mo. follow-up
3.554199
9,002
75.60297
0
female
0
16
472
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
17,139
10,977.4531
11,774.9531
13.333328
white
26.699219
18
0.695923
0.531982
1
0
0
no
0.8
0.7
no dnr
16
117
8.099609
122
36
38.59375
338.0625
3.399902
0.599976
0.699951
128
7.489258
274
17
1,200
null
2
no(M2 and SIP pres)
2
9,003
81.72198
1
male
0
4
437
COPD
COPD/CHF/Cirrhosis
3
8
under $11k
0
3,043
2,024.9912
2,515.10938
16
white
15
19
0.80188
0.680908
1
0
0
yes
0.99
0.9
dnr after sadm
2
113
8.699219
98
42
38.09375
124
3
0.899902
0.899902
141
7.459961
286
33
1,910
null
null
no(M2 and SIP pres)
2.884766
9,004
57.396
1
female
0
19
69
Colon Cancer
Cancer
2
10
under $11k
0
13,334
8,906.5859
8,470.92969
6.666664
other
23.796875
17
0.724976
0.450989
1
1
0
metastatic
0.6
0.2
dnr after sadm
1
78
18.199219
140
22
37.79688
null
3.399902
0.799927
1
128
null
133
14
2,900
0
4
SIP>=30
4
9,005
60.64099
0
male
0
4
468
COPD
COPD/CHF/Cirrhosis
1
10
null
0
2,783
1,856.5303
2,369.85938
6
white
19
16
0.890991
0.817993
1
0
0
no
0.85
0.8
no dnr
4
125
13.298828
100
24
38.79688
null
2
0.199982
2.599609
149
null
162
54
1,350
0
null
no(M2 and SIP pres)
0.494751
9,006
73.00195
0
female
0
19
469
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
0
24,180
15,589.9375
18,584.8281
16.333328
white
25.5
36
0.698975
0.608887
1
0
0
yes
null
null
dnr after sadm
14
70
8.199219
172
24
36.09375
153.03125
2.699707
1
1
144
7.399414
113
46
4,225
1
1
adl>=4 (>=5 if sur)
1
9,007
40.19699
0
female
0
29
466
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
63,906
42,971.0625
46,177
26
white
24.199219
44
0.8479
0.795898
5
0
0
no
null
null
no dnr
29
119
16.597656
118
32
36.19531
308
3.299805
0.399963
0.699951
138
7.459961
310
18
2,025
null
null
no(M2 and SIP pres)
1.858154
9,008
75.19196
1
male
1
8
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
44
31,223
20,360.9844
19,235.6875
52
white
28.597656
37
0.491943
0.373962
1
1
0
no
0.1
0.1
dnr after sadm
7
57
11.199219
66
14
38.59375
262.5
2.699707
0.5
0.799927
139
7.459961
84
18
580
null
2
<2 mo. follow-up
2
9,009
42.61499
0
male
0
18
461
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
48,707
32,075.2656
32,547.75
25.666656
white
18.199219
29
0.916992
0.886963
1
0
0
no
0.6
0.6
no dnr
18
117
6.599609
67
24
36.39844
308.6875
4.099609
1
1.899902
138
7.469727
216
31
1,550
null
0
SIP>=30
0
9,010
64.29297
1
female
0
11
84
COPD
COPD/CHF/Cirrhosis
4
null
null
37
16,955
11,483.3438
13,552.8594
23.5
white
26.5
37
0.592896
0.401978
1
0
0
yes
0.75
0.75
no dnr
11
106
6.5
93
16
36.09375
null
4.399414
0.399963
1.199951
139
null
108
16
2,475
null
null
null
4.527344
9,011
63.866
1
male
0
4
21
Lung Cancer
Cancer
2
12
$25-$50k
0
2,016
1,293.1191
1,384.15918
5
white
18.398438
21
0.681885
0.386963
1
1
0
metastatic
0.2
0.5
no dnr
4
72
null
106
10
35.69531
null
null
null
1.399902
136
null
152
27
2,370
1
5
<2 mo. follow-up
5
9,012
40.241
1
female
1
6
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
$25-$50k
0
59,750
43,047.4375
37,539.2812
51
white
41.195313
66
0.462952
0.343994
29
1
0
no
null
null
dnr after sadm
6
84
8.398438
76
20
36.39844
null
null
null
1.199951
134
null
159
20
null
null
null
<2 mo. follow-up
2.271484
9,013
70.80896
0
male
0
24
460
COPD
COPD/CHF/Cirrhosis
3
21
$11-$25k
0
28,045
null
null
19.666656
white
21.398438
27
0.81897
0.705933
1
0
0
no
0.8
0.6
no dnr
24
120
8.199219
83
24
35.79688
247.59375
null
0.699951
0.799927
138
7.40918
84
13
null
0
0
no(M2 and SIP pres)
0
9,014
74.52197
1
female
0
3
309
CHF
COPD/CHF/Cirrhosis
5
8
$11-$25k
0
2,172
1,436.1357
1,715.0293
4
white
38.695313
40
0.343994
0.155975
1
1
0
yes
0.7
0.6
no dnr
3
67
23.398438
98
24
35.79688
195.21875
2.699707
0.299988
0.599976
131
7.419922
141
14
null
null
null
no(M2 and SIP pres)
2.848633
9,015
65.71399
0
male
0
5
454
COPD
COPD/CHF/Cirrhosis
1
11
$25-$50k
0
3,842
2,439.6562
2,197.91992
10
white
9
20
0.940918
0.898926
1
0
0
no
0.8
0.8
no dnr
5
81
13.398438
73
24
36.09375
204
null
null
1.199951
142
7.349609
191
33
3,175
1
0
no(M2 and SIP pres)
0
9,016
88.46497
0
female
0
8
453
MOSF w/Malig
ARF/MOSF
0
8
null
9
19,050
12,381.9688
11,637.8594
10
white
18.398438
21
0.691895
0.599976
6
0
0
yes
null
null
no dnr
8
63
7.699219
64
16
36.29688
null
3.399902
0.399963
1.299805
134
null
101
24
950
5
6
no(M2 and SIP pres)
6
9,017
68.41095
1
male
0
22
46
Coma
Coma
1
14
$25-$50k
26
50,312
33,776.4688
35,563.0312
17.666656
white
16.398438
22
0.633911
0.571899
20
0
0
no
0.5
0.3
dnr after sadm
2
63
6.099609
106
10
39
420
2.899902
1.299805
0.599976
131
7.439453
141
12
2,500
0
0
<2 mo. follow-up
0
9,018
75.16998
0
female
0
13
451
COPD
COPD/CHF/Cirrhosis
3
8
null
26
13,763
9,029.9922
8,189.79688
15
white
23.796875
57
0.665894
0.491943
1
0
0
no
0.75
0.75
no dnr
13
119
13.199219
104
28
35.59375
264
3.599609
0.799927
1.099854
131
7.269531
316
21
null
null
0
no(M2 and SIP pres)
0
9,019
66.96198
1
female
1
59
59
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
100
191,281
null
null
42.75
white
29
65
0.128998
0.057999
39
0
0
no
0.2
0
dnr after sadm
29
52
10.798828
72
34
38.59375
153.3125
1.599854
4.5
1
140
7.479492
131
24
4,105
null
0
<2 mo. follow-up
0
9,020
78.10498
0
male
0
95
447
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
9
177,145
120,634.875
129,924.25
28.25
white
25.699219
50
0.611938
0.505981
13
0
0
no
null
null
no dnr
95
72
14.199219
68
8
37.89844
190
4.399414
0.299988
1.099854
137
7.389648
181
15
2,915
null
0
adl>=4 (>=5 if sur)
0
9,021
74.90198
0
male
0
8
446
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
0
5,133
3,393.2227
3,857.24805
7
white
15.199219
21
0.870972
0.785889
1
0
0
no
null
null
dnr after sadm
1
98
11.5
69
22
36.19531
null
null
1.099854
1.099854
139
null
116
13
null
0
0
no(M2 and SIP pres)
0
9,022
67.40295
1
female
0
4
159
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
2,456
1,675.9453
1,609.0498
2
white
16.296875
15
0.889893
0.814941
1
0
0
no
0.8
0.4
dnr after sadm
3
67
7.599609
57
20
35.69531
null
4.699219
1.399902
1.799805
139
null
88
35
2,000
2
null
no(M2 and SIP pres)
1.838867
9,023
71.54297
0
male
0
7
445
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
5,544
3,609.9824
3,011.10938
3.5
white
25.398438
36
0.765991
0.628906
1
0
0
no
0.7
0.6
no dnr
7
76
10
121
24
36.19531
540
null
null
1.399902
133
7.509766
110
24
1,250
0
0
no(M2 and SIP pres)
0
9,024
48.89798
1
female
1
7
7
Coma
Coma
3
null
null
100
22,480
16,014.5625
14,999.1797
10.5
white
25.398438
49
0.246979
0.181
6
0
0
no
0.35
0.35
no dnr
7
76
9.798828
60
14
36.39844
null
null
null
4.399414
132
null
143
86
3,550
null
null
<2 mo. follow-up
3.05127
9,025
58.26099
0
female
0
46
442
Coma
Coma
4
9
under $11k
44
47,880
30,861.125
47,698.1875
17
white
23.796875
27
0.480957
0.407959
1
1
0
yes
0.5
0.4
dnr after sadm
1
65
8.898438
63
27
38.09375
320
2.699707
1.5
1.399902
146
7.399414
177
30
3,750
null
0
adl>=4 (>=5 if sur)
0
9,026
64.25494
0
male
0
4
442
COPD
COPD/CHF/Cirrhosis
4
9
under $11k
0
2,845
1,856.4043
1,873.64941
8
white
15.199219
15
0.884888
0.80896
1
0
0
yes
0.9
0.9
no dnr
4
64
13.599609
100
28
36.19531
105
3
4.899414
0.799927
131
7.479492
155
19
1,400
null
null
null
2.475586
9,027
53.38797
1
male
0
20
184
MOSF w/Malig
ARF/MOSF
1
12
null
0
44,781
81,412.1875
79,421.375
24.333328
white
26.597656
55
0.550903
0.437988
24
0
0
yes
0.6
0.5
no dnr
20
108
15
80
10
39.5
401
4.099609
0.899902
1.799805
140
7.479492
161
15
2,250
0
0
no(M2 and SIP pres)
0
9,028
54.48898
0
male
0
19
440
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
55,248
37,118.6562
36,838.3125
24.666656
white
25.296875
35
0.754883
0.67688
7
0
0
no
0.8
0.8
no dnr
19
108
11
58
10
36.29688
156
3.799805
0.799927
1.199951
143
7.5
182
32
825
null
0
no(M2 and SIP pres)
0
9,029
59.96698
1
male
1
15
15
ARF/MOSF w/Sepsis
ARF/MOSF
5
5
$11-$25k
100
27,965
20,384.6875
19,829.9219
34.333313
white
46.398438
85
0.007
0.001
1
1
0
no
0.25
0.5
no dnr
15
107
5.899414
72
7
36.09375
158
3.199707
0.599976
1.099854
141
7.489258
133
33
700
null
6
<2 mo. follow-up
6
9,030
58.64999
1
male
0
17
394
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
9
19,976
13,563.8828
12,909.9297
17.333328
white
25
45
0.791992
0.723999
1
0
0
no
0.5
0.4
no dnr
17
117
1
76
20
36.59375
null
4.199219
0.899902
0.899902
139
null
169
21
2,150
null
null
null
2.914063
9,031
57.50897
0
female
0
5
436
COPD
COPD/CHF/Cirrhosis
2
10
null
0
3,509
2,254.9258
2,080.41992
5
white
14.898438
10
0.928955
0.878906
1
0
0
no
0.9
0.8
no dnr
5
77
19.796875
104
20
36.09375
null
2.799805
1.099854
1.199951
120
null
155
28
null
1
null
no(M2 and SIP pres)
1.166748
9,032
41.66998
0
male
0
47
436
COPD
COPD/CHF/Cirrhosis
7
12
under $11k
0
91,054
null
null
31.75
white
49.898438
97
0.399963
0.201996
6
1
0
no
0.3
0.3
no dnr
47
55
29.097656
50
14
36.69531
163.25
3.799805
2.399902
2.899902
132
7.429688
202
68
2,350
null
null
adl>=4 (>=5 if sur)
3.859863
9,033
75.737
0
female
0
6
436
COPD
COPD/CHF/Cirrhosis
2
null
null
0
4,229
2,747.5625
2,469.00977
8
white
15.298828
23
0.865967
0.777954
1
0
0
no
null
null
dnr after sadm
1
79
8.099609
60
20
35.69531
null
4.5
1.099854
1.299805
136
null
104
28
2,900
null
null
no(M2 and SIP pres)
2.251465
9,034
73.98999
0
male
0
6
436
CHF
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
4,473
2,867.5469
2,806.33984
9
white
18.796875
24
0.810913
0.69397
1
0
0
yes
null
null
dnr after sadm
1
68
10.798828
78
28
36
456.625
null
0.599976
1.199951
128
7.459961
124
23
1,380
1
1
no(M2 and SIP pres)
1
9,035
60.68997
0
male
0
9
436
CHF
COPD/CHF/Cirrhosis
3
9
$11-$25k
0
10,136
6,580.168
5,716.26953
7
white
16.597656
15
0.876953
0.795898
1
0
0
yes
0.95
0.8
no dnr
9
99
6.299805
74
20
36.09375
309.5
null
null
1.099854
143
7.449219
154
16
3,750
null
null
no(M2 and SIP pres)
2.611328
9,036
61.81799
1
female
0
17
77
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
$25-$50k
0
52,105
74,461.5625
80,589.5625
39.333313
white
22.597656
40
0.770996
0.696899
3
0
0
yes
0.25
0.25
dnr after sadm
1
113
17.597656
114
28
36.09375
260
3.199707
0.299988
0.699951
136
7.399414
210
12
625
null
1
SIP>=30
1
9,037
77.27594
1
male
0
7
109
CHF
COPD/CHF/Cirrhosis
6
10
>$50k
0
5,305
3,511.0664
3,154.50977
4
white
29.796875
40
0.574951
0.381958
1
0
0
yes
null
null
no dnr
7
79
13.5
68
24
35.59375
276.1875
3.399902
0.5
1.699951
137
7.319336
255
45
1,250
1
1
no(M2 and SIP pres)
1
9,038
81.36896
1
female
1
27
27
MOSF w/Malig
ARF/MOSF
1
12
$11-$25k
0
49,066
34,163.25
34,912.1562
22.25
white
30.097656
48
0.524902
0.408997
1
0
0
yes
0.8
0.6
dnr after sadm
26
105
1.699951
128
35
38.19531
80
null
0.5
1.099854
127
7.519531
175
22
3,850
null
1
<2 mo. follow-up
1
9,039
68.39398
1
female
0
15
28
Lung Cancer
Cancer
3
null
null
0
15,760
10,211.2812
8,562.27344
7.666664
white
21.199219
20
0.605957
0.28894
1
0
0
metastatic
0.4
0.3
no dnr
15
115
9.798828
74
20
36.09375
null
3.799805
1.799805
1.299805
137
null
111
27
1,900
1
2
<2 mo. follow-up
2
9,040
70.67499
0
female
0
7
430
COPD
COPD/CHF/Cirrhosis
3
14
null
0
6,195
3,941.9727
3,448.26953
6
white
16.199219
33
0.87793
0.796997
1
1
0
no
0.5
0.3
dnr before sadm
-1
71
13.099609
54
20
36.89844
null
4.699219
0.5
1.199951
134
null
194
16
2,875
4
null
no(M2 and SIP pres)
3.183106
9,041
68.10394
0
female
0
20
430
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
61,528
41,360.8438
43,886.8438
21.666656
white
27.296875
36
0.688965
0.595947
6
0
0
no
0.5
0.4
no dnr
20
87
1.799805
64
22
36.29688
null
4
0.799927
1.099854
134
null
118
9
3,100
null
0
null
0
9,042
63.59799
1
female
0
5
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
38,249
23,373.0781
24,709.9062
23
white
19.5
50
0.81189
0.75
28
0
0
no
0.1
0
dnr after sadm
1
80
12.099609
74
22
36.39844
null
null
null
0.799927
135
null
205
12
2,225
null
2
<2 mo. follow-up
2
9,043
80.12897
1
male
0
10
55
Cirrhosis
COPD/CHF/Cirrhosis
1
8
null
9
6,034
4,013.293
3,842.2793
7
white
18.5
28
0.648926
0.470947
1
0
0
no
0.5
0.3
dnr after sadm
9
63
6.5
122
40
36
128.5625
null
1.099854
1.099854
142
7.379883
126
45
null
null
5
<2 mo. follow-up
5
9,044
72.76898
1
male
1
6
6
Coma
Coma
3
11
null
37
14,014
9,511.0781
9,680.61719
35
white
33.296875
66
0.116989
0.071991
1
0
0
yes
null
null
no dnr
6
64
1.699951
69
24
36.5
366.625
4.199219
0.899902
1.199951
134
7.439453
127
11
1,925
null
null
<2 mo. follow-up
2.409668
9,045
58.26099
0
male
0
17
423
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
$25-$50k
0
58,584
39,209.1562
42,428.875
33.333313
white
31.296875
58
0.667969
0.571899
4
0
0
no
0.8
0.512
no dnr
17
69
16.796875
117
26
36.89844
400
null
null
5.099609
134
7.459961
135
80
220
null
0
no(M2 and SIP pres)
0
9,046
76.53894
1
male
0
5
129
Lung Cancer
Cancer
1
8
null
0
4,560
2,875.1504
2,534.88867
9
white
10.5
11
0.796997
0.56897
1
0
0
metastatic
0.7
0.3
no dnr
5
44
0.299988
170
24
38.29688
183.65625
3
0.899902
5
137
7.369141
237
96
5
null
null
no(M2 and SIP pres)
1.930908
9,047
91.30695
0
female
0
3
421
CHF
COPD/CHF/Cirrhosis
6
9
null
0
1,573
1,085.8164
1,157.38965
null
white
18.699219
20
0.736938
0.587891
1
0
1
yes
0.5
0.3
dnr after sadm
1
110
10.599609
62
24
36
283.3125
3
0.899902
0.899902
138
7.449219
110
11
2,600
null
null
null
5.493164
9,048
46.836
0
male
0
70
423
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
44
59,768
64,931.875
65,340.1562
20
white
20
13
0.814941
0.75293
1
0
0
no
0.1
0.1
no dnr
70
158
27.296875
118
29
36.39844
220
null
null
1
142
7.589844
171
16
1,800
null
0
adl>=4 (>=5 if sur)
0
9,049
77.69995
0
male
0
9
421
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
0
9,447
6,500.4805
7,083.86719
9.5
white
16.898438
20
0.856934
0.807983
1
0
0
no
0.9
0.9
no dnr
9
77
6.199219
140
28
35.29688
338.0625
3.899902
0.5
3.599609
137
7.339844
88
49
800
0
0
no(M2 and SIP pres)
0
9,050
61.09497
1
male
0
13
52
Colon Cancer
Cancer
2
12
null
0
15,908
10,149.2031
10,831.7188
18.5
white
18.097656
13
0.809937
0.592896
1
0
0
metastatic
0.5
0.25
dnr after sadm
1
104
null
118
18
36.09375
null
null
null
0.799927
133
null
128
18
3,350
0
0
<2 mo. follow-up
0
9,051
30.683
1
male
1
10
10
Coma
Coma
1
null
null
100
20,055
14,092.5156
16,231.6641
33
other
27.296875
38
0.459961
0.385986
1
0
0
no
null
null
dnr after sadm
7
101
17.398438
77
12
36.39844
177.125
null
null
0.799927
139
7.369141
132
15
1,975
null
null
<2 mo. follow-up
3.193359
9,052
72.24896
0
male
0
6
420
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
13,811
10,387.7812
10,449.4062
29
white
21.097656
28
0.822998
0.762939
1
0
0
no
0.75
0.75
no dnr
6
78
7.299805
59
24
36.29688
323.75
null
0.599976
2
137
7.389648
203
51
null
null
null
null
1.744873
9,053
59.59998
0
male
0
23
417
COPD
COPD/CHF/Cirrhosis
0
12
null
0
35,184
23,657.5312
25,296.1719
28.666656
white
29.898438
48
0.763916
0.625
1
0
0
no
0.6
0.55
no dnr
23
63
null
112
24
36.09375
null
null
null
1.299805
136
null
104
16
2,225
null
0
adl>=4 (>=5 if sur)
0
9,054
45.35498
0
female
0
44
418
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
83,628
null
null
15.5
white
27
52
0.772949
0.699951
2
0
0
yes
0.8
0.7
no dnr
44
81
8.699219
53
24
35.09375
null
3.299805
0.5
1.699951
131
null
108
33
3,100
0
0
SIP>=30
0
9,055
76.25995
1
female
1
23
23
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
62,544
44,539.9062
38,243.4688
41.333313
white
28.5
55
0.681885
0.588989
1
1
0
no
0.49
0.49
dnr after sadm
13
120
17
76
32
36.59375
183.3125
null
null
2
141
7.40918
202
40
1,920
null
0
<2 mo. follow-up
0
9,056
74.05896
1
female
0
17
79
Lung Cancer
Cancer
1
11
$11-$25k
0
13,262
8,684.1641
9,621.92969
12
white
18.699219
14
0.649902
0.343994
1
0
0
metastatic
0.5
0.2
no dnr
17
56
17.796875
76
10
36
111.65625
2.199707
0.599976
1.399902
151
7.429688
76
39
2,625
5
7
adl>=4 (>=5 if sur)
7
9,057
56.60498
0
male
0
10
412
COPD
COPD/CHF/Cirrhosis
2
8
null
0
18,098
12,675.5469
14,040.2969
24.5
white
24.699219
38
0.851929
0.756958
1
0
0
no
0.9
0.9
no dnr
10
48
12.298828
137
9
38.19531
97.76562
null
null
0.599976
140
7.429688
256
10
1,100
null
1
no(M2 and SIP pres)
1
9,058
65.51697
1
female
0
15
80
CHF
COPD/CHF/Cirrhosis
5
10
null
0
16,334
11,352.4531
9,983.50781
10.333328
white
23
29
0.824951
0.715942
1
1
0
no
0.75
0.6
no dnr
15
74
12.298828
134
36
39.5
234.28125
null
null
0.699951
140
7.509766
224
21
2,285
null
null
adl>=4 (>=5 if sur)
3.375488
9,059
69.67297
0
male
0
11
411
CHF
COPD/CHF/Cirrhosis
3
17
>$50k
0
15,937
10,393.5
9,543.625
23
white
19.398438
34
0.853882
0.759888
1
1
0
no
0.8
0.8
dnr after sadm
2
66
12.599609
79
20
36.39844
null
3.699707
0.399963
1.199951
135
null
124
21
2,800
null
2
no(M2 and SIP pres)
2
9,060
36.73398
0
male
0
12
409
MOSF w/Malig
ARF/MOSF
2
13
$25-$50k
0
24,756
16,661.5625
15,449.0938
25.5
white
35.09375
48
0.419983
0.300964
3
0
0
yes
0.4
0.3
no dnr
12
71
9.599609
60
20
36.19531
247.59375
null
null
null
140
7.399414
null
null
1,650
null
0
no(M2 and SIP pres)
0
9,061
65.96594
0
female
0
9
408
COPD
COPD/CHF/Cirrhosis
0
12
null
0
8,106
5,174.0039
7,386.21875
7.5
white
19.5
24
0.865967
0.777954
1
0
0
no
0.7
0.5
no dnr
9
75
11.298828
74
20
35.5
460
null
null
1.199951
143
7.389648
154
21
1,050
0
2
no(M2 and SIP pres)
2
9,062
77.58197
1
female
0
5
6
MOSF w/Malig
ARF/MOSF
1
null
null
0
22,607
15,861.0156
16,418.1562
32
white
20
26
0.657959
0.55896
4
0
0
metastatic
null
null
no dnr
5
47
23.898438
102
24
38.19531
215.6875
2.099609
2
0.799927
130
7.399414
230
17
1,162
null
null
<2 mo. follow-up
2.355469
9,063
44.44397
1
male
1
8
8
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$11-$25k
0
26,887
18,224.4375
23,413.7188
34.5
white
26.796875
40
0.813965
0.751953
3
0
0
no
0.3
0.3
no dnr
8
119
12.199219
79
16
36.29688
null
2.899902
0.5
0.599976
139
null
142
12
3,650
null
0
<2 mo. follow-up
0
9,064
65.96594
1
male
0
5
320
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
0
3,082
2,044.9668
2,643.20898
11
white
26.398438
43
0.622925
0.437988
1
1
0
no
0.8
0.4
no dnr
5
48
5.099609
79
16
36.29688
null
3.899902
0.5
1.399902
136
null
205
14
3,750
3
2
no(M2 and SIP pres)
2
9,065
36.81
1
female
1
25
25
MOSF w/Malig
ARF/MOSF
1
14
null
0
127,198
82,520.25
87,494.75
36
white
45.59375
78
0.045998
0.014
13
0
0
metastatic
0.75
0.7
no dnr
25
79
8.298828
104
24
36.19531
319
null
0.5
0.699951
131
7.399414
110
5
4,800
null
0
<2 mo. follow-up
0
9,066
79.61694
1
male
0
14
35
Lung Cancer
Cancer
1
12
null
0
8,930
5,929.5664
5,859.21875
9.333328
white
14.599609
6
0.720947
0.44397
1
0
0
metastatic
0.4
0.1
no dnr
14
64
8
112
24
38.69531
314.25
4.299805
0.599976
1.199951
139
7.519531
123
16
1,775
null
0
<2 mo. follow-up
0
9,067
69.36597
0
male
0
6
405
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
6,555
4,531.9766
4,346.07812
16
white
26.597656
38
0.750977
0.671997
1
0
0
no
0.95
0.9
no dnr
6
120
10.898438
110
32
35.5
163.25
2.5
0.299988
1.099854
149
7.449219
149
30
4,375
0
0
no(M2 and SIP pres)
0
9,068
50.41199
0
male
0
15
403
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
51,775
35,385.375
36,503.4062
29.333328
white
25.796875
33
0.794922
0.727905
5
0
0
no
0.9
0.9
no dnr
15
133
24.796875
120
10
39
126.14062
2.799805
1.399902
3.199707
150
7.329102
81
64
840
null
0
SIP>=30
0
9,069
75.13995
0
male
0
37
403
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
9
59,514
38,261.4688
40,055.5312
22.75
white
21.898438
41
0.763916
0.687988
2
0
0
no
null
null
no dnr
37
81
13.398438
64
16
36.29688
195.90625
null
0.699951
1.099854
138
6.829102
320
20
1,925
null
null
null
2.601074
9,070
53.21298
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
44
18,549
12,547.3359
17,883.6094
45
white
27.898438
35
0.644897
0.544922
1
1
0
no
0.25
0.2
dnr after sadm
1
59
19.199219
130
12
36.39844
131.09375
3
0.799927
2.199707
135
7.359375
123
60
3,105
null
0
<2 mo. follow-up
0
9,071
77.33295
1
female
0
3
20
Lung Cancer
Cancer
2
12
$11-$25k
0
1,212
805.0625
846.78955
3
white
15.199219
14
0.715942
0.435974
1
0
0
metastatic
0.4
0.2
dnr after sadm
1
67
7.799805
74
28
38.39844
154.28125
null
0.899902
1.099854
143
7.419922
165
18
1,025
0
0
<2 mo. follow-up
0
9,072
48.405
1
female
1
11
11
MOSF w/Malig
ARF/MOSF
1
13
null
44
76,273
49,159.5
51,156.3125
45
white
44.695313
91
0.004
0.001
7
0
0
metastatic
0.5
0.48
dnr after sadm
9
65
10.699219
74
24
36.19531
192
null
null
1
144
7.399414
104
22
2,600
null
0
<2 mo. follow-up
0
9,073
49.11697
0
male
0
6
394
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
5,799
3,943.543
3,946.1582
12
white
15.599609
27
0.942993
0.902954
1
0
0
no
null
null
no dnr
6
109
3.5
71
24
36.19531
336
2.399902
8.199219
0.899902
137
7.259766
139
11
null
null
null
null
2.98584
9,074
70.36798
0
male
0
4
394
COPD
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
4,504
3,093.8516
3,748.84961
11
white
20.398438
18
0.834961
0.72998
1
0
0
no
null
null
no dnr
4
67
6.899414
66
28
36.29688
238.09375
4.5
1.5
2
143
7.449219
143
53
1,175
null
null
no(M2 and SIP pres)
2.3125
9,075
66.146
1
male
1
12
12
MOSF w/Malig
ARF/MOSF
2
null
under $11k
37
53,671
37,465.8438
36,988
33.5
white
23.199219
50
0.430969
0.311951
40
0
0
yes
null
null
dnr after sadm
6
59
8.798828
128
40
36.29688
null
2.5
1.899902
1.399902
134
null
108
24
2,700
null
null
<2 mo. follow-up
2.387695
9,076
63.43298
1
male
0
3
143
Lung Cancer
Cancer
2
10
null
0
1,822
1,216.1992
1,412
null
white
13.099609
9
0.779907
0.540894
1
0
0
metastatic
null
null
no dnr
3
71
16.597656
48
16
36.19531
null
2.5
0.299988
0.799927
131
null
77
15
1,500
null
null
null
2.046875
9,077
59.53198
1
female
0
13
22
Coma
Coma
0
13
>$50k
89
22,471
18,157.375
19,222.3906
26
white
21.597656
14
0.385986
0.312988
1
0
0
no
null
null
dnr after sadm
7
59
14.798828
94
10
38.09375
282.5
null
null
1.699951
133
7.5
405
31
2,750
null
0
<2 mo. follow-up
0
9,078
62.84998
0
male
0
93
391
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
188,562
128,103.5
131,823.5
35.75
white
17.796875
8
0.882935
0.841919
1
1
0
no
null
null
dnr after sadm
55
65
19.296875
140
22
36.59375
195
null
null
2
132
7.449219
137
58
2,570
null
2
adl>=4 (>=5 if sur)
2
9,079
76.72797
1
male
0
4
242
Lung Cancer
Cancer
1
12
null
0
10,134
6,054.043
5,996.03906
10
white
6.299805
15
0.850952
0.670898
1
0
0
metastatic
0.99
0.75
no dnr
4
91
3.299805
67
16
36.09375
null
3.599609
0.5
0.899902
136
null
97
9
1,475
null
null
no(M2 and SIP pres)
1.775391
9,080
53.32498
1
male
0
5
308
Lung Cancer
Cancer
2
12
$25-$50k
0
5,467
3,386.6055
1,845.12988
11
white
11
18
0.827881
0.625977
1
1
0
metastatic
0.6
0.3
no dnr
5
71
8
135
20
36.39844
230.40625
null
1.299805
1.099854
137
7.30957
118
19
1,510
null
null
no(M2 and SIP pres)
1.976563
9,081
51.47998
0
male
0
40
386
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
33,830
22,221.5781
18,956.8906
10.25
white
35.296875
70
0.662964
0.564941
1
1
0
no
0.9
0.85
no dnr
40
60
0.199982
160
34
38.39844
null
2.799805
0.899902
1
141
null
169
26
null
null
2
null
2
9,082
54.05298
1
male
0
9
272
Lung Cancer
Cancer
1
12
$25-$50k
0
7,228
4,629.1406
4,348.85938
9.5
white
18.097656
18
0.710938
0.429993
1
0
0
metastatic
0.5
0.2
no dnr
9
125
12.699219
78
25
38.29688
256
1.899902
2
1.299805
144
7.479492
121
47
3,100
0
0
no(M2 and SIP pres)
0
9,083
75.40594
1
male
1
10
10
Coma
Coma
2
null
null
89
32,243
21,154.6875
22,736.2344
39
white
27.097656
50
0.050995
0.025997
1
1
0
yes
0.1
0.02
dnr after sadm
6
109
15.398438
110
30
36.19531
222.5
3.699707
0.799927
0.899902
140
7.239258
147
18
1,515
null
0
<2 mo. follow-up
0
9,084
85.66498
1
female
1
4
4
Coma
Coma
1
8
under $11k
100
3,906
2,507.3887
2,277.03906
19
white
17.699219
28
0.181976
0.123993
1
1
0
no
0.1
0
dnr after sadm
1
102
24.296875
70
20
35.89844
null
null
null
1.199951
137
null
158
11
null
null
1
<2 mo. follow-up
1
9,085
65.06195
1
female
0
16
376
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
null
0
19,709
13,702.2266
13,249.0234
19.333328
white
25.597656
44
0.783936
0.713989
1
1
0
no
null
null
no dnr
16
109
7.399414
63
16
35.39844
null
2.899902
1
1.299805
139
null
130
27
null
1
0
no(M2 and SIP pres)
0
9,086
18.41499
0
male
0
9
380
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
>$50k
0
22,047
13,396.9062
14,879.5469
23
white
19.699219
17
0.910889
0.878906
4
0
0
yes
0.98
0.96
no dnr
9
65
38.398438
104
30
36
152.5
null
1
1.299805
132
7.419922
243
25
1,225
null
0
null
0
9,087
70.48297
0
male
0
4
364
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
2,787
1,799.1553
1,919.35938
7
white
21.199219
26
0.780884
0.649902
1
0
0
yes
0.9
0.9
no dnr
4
93
15.5
69
32
36
280.9375
null
0.399963
1.199951
139
7.399414
144
32
950
null
null
no(M2 and SIP pres)
2.322266
9,088
75.50696
0
male
0
23
364
COPD
COPD/CHF/Cirrhosis
1
13
$11-$25k
41
45,129
30,240.5156
37,300.8438
34
white
22.398438
29
0.633911
0.450989
1
0
0
no
0.5
0.35
dnr after sadm
16
102
null
71
24
35.89844
null
null
null
null
140
null
null
null
null
null
0
no(M2 and SIP pres)
0
9,089
51.452
1
female
0
3
337
Lung Cancer
Cancer
1
12
$11-$25k
0
8,023
4,859.3516
3,317.91992
11
white
13.699219
12
0.793945
0.563965
1
0
0
metastatic
0.99
0.99
no dnr
3
118
9.599609
60
16
36.19531
null
3.599609
0.399963
2.599609
135
null
154
59
1,450
null
null
no(M2 and SIP pres)
1.922607
9,090
74.62
0
male
0
9
361
CHF
COPD/CHF/Cirrhosis
5
12
null
0
6,963
4,772.4609
5,048.37891
10
white
20.796875
25
0.777954
0.645996
1
1
0
yes
null
null
no dnr
9
66
8.398438
132
23
38.59375
215
2.099609
1.899902
0.799927
143
7.399414
280
38
2,650
0
0
null
0
9,091
64.51196
0
male
0
14
361
COPD
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
23,105
16,030.1719
15,379.2188
18
white
32.398438
60
0.654907
0.477966
2
0
0
no
0.3
0.15
no dnr
14
49
19.5
116
34
36
208.5625
2.599609
0.399963
2.699707
136
7.289062
175
50
1,205
null
0
no(M2 and SIP pres)
0
9,092
79.17596
0
male
0
27
359
COPD
COPD/CHF/Cirrhosis
2
4
under $11k
9
20,070
13,088.1406
14,808.3359
7
white
22.097656
28
0.724976
0.570923
1
0
0
no
0.9
0.5
dnr after sadm
20
80
15.798828
107
32
35.69531
328
3
0.299988
0.699951
135
7.449219
149
11
1,150
0
0
no(M2 and SIP pres)
0
9,093
75.948
0
male
0
13
359
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
null
26
25,038
17,292.6562
15,560.1797
14.5
white
21.597656
43
0.685913
0.593994
4
0
0
no
null
null
no dnr
13
71
4.599609
67
24
36.29688
252.375
null
0.399963
1.299805
141
7.379883
113
32
null
null
2
no(M2 and SIP pres)
2
9,094
69.64795
1
female
1
14
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
44
44,632
29,434.5938
39,811.7188
29.333328
white
26.199219
49
0.589966
0.480957
1
0
0
no
0.7
0.85
dnr after sadm
13
178
8.199219
76
20
36.19531
null
2.899902
0.299988
0.699951
132
null
144
8
3,320
null
3
<2 mo. follow-up
3
9,095
18.04199
0
female
0
12
358
MOSF w/Malig
ARF/MOSF
0
null
null
0
32,141
null
null
18
white
29.296875
57
0.600952
0.493958
4
0
0
yes
null
null
no dnr
12
77
11.599609
60
24
35.69531
240
null
null
0.899902
140
7.419922
159
18
null
null
null
null
2.147461
9,096
80.60199
1
female
0
6
295
CHF
COPD/CHF/Cirrhosis
3
8
null
0
4,047
2,704.1426
2,058.89844
12
white
14.898438
33
0.869995
0.783936
1
1
0
no
0.7
0.5
no dnr
6
69
23.5
104
20
36.19531
184
null
0.699951
0.699951
132
7.489258
170
7
1,175
2
null
no(M2 and SIP pres)
1.838867
9,097
66.05597
0
male
0
17
356
Coma
Coma
1
12
$11-$25k
44
19,160
12,187.2031
11,979.5625
10.333328
white
13.898438
19
0.664917
0.606934
1
0
0
yes
0.2
0.1
dnr after sadm
1
56
65.59375
134
10
38.69531
349.0625
null
null
0.799927
142
7.449219
127
19
1,570
null
0
no(M2 and SIP pres)
0
9,098
64.48499
0
female
0
3
356
Lung Cancer
Cancer
2
11
$11-$25k
0
6,830
4,100.5508
3,053.67969
null
white
10.398438
14
0.817993
0.60791
1
1
0
metastatic
0.99
0.99
no dnr
3
64
6.199219
116
8
39.39844
175
3
null
1.699951
129
7.359375
278
59
3,828
null
null
no(M2 and SIP pres)
1.942871
9,099
70.42297
1
male
0
15
17
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
null
0
80,504
56,370.8125
55,285.375
40.666657
white
29.398438
60
0.531982
0.416992
11
1
0
yes
0.5
0.5
dnr after sadm
13
129
24.597656
57
10
37.5
217
null
null
1.199951
136
7.419922
179
22
2,010
null
null
<2 mo. follow-up
2.714844
9,100
68.61597
0
female
0
4
353
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
2,758
1,847.376
1,976.73926
3
white
15.298828
19
0.865967
0.778931
1
0
0
yes
null
null
dnr after sadm
1
71
12.599609
110
10
36.19531
135
4.099609
0.599976
0.799927
128
7.489258
142
17
950
0
null
no(M2 and SIP pres)
0.494751